Pharmacovigilance, the science of drug safety and adverse event monitoring, is crucial for protecting patient health and ensuring pharmaceutical integrity. Featured.com's expert directory showcases top professionals in this vital field, connecting authoritative voices with leading publishers and media outlets. Our curated list includes pharmacovigilance specialists who have been featured in respected medical journals and industry publications, offering insights on post-market surveillance, risk management strategies, and emerging trends in drug safety. For publishers seeking credible sources on pharmaceutical safety, this directory provides quick access to experienced professionals. For pharmacovigilance experts, it's an opportunity to share knowledge, gain visibility, and contribute to critical discussions in healthcare. Explore our directory to find or connect with trusted pharmacovigilance experts who can provide valuable perspectives for your next article, interview, or research project.
Connect directly with our network of vetted pharmacovigilance experts for interviews, quotes, or in-depth analysis.
Many experts respond within hours to media requests
All experts undergo background and credential verification
No fees to connect with experts for legitimate media requests
Join our network of professionals and connect with journalists and publishers looking for your expertise.
Showing 20 of 26 experts
Associate professor - Epidemiology at North Dakota State University
Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.
Featured In:
RPh, ABAAHP at Fusion Medical Care
I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.
Featured In:
Author , Student researcher unaffiliated
Swalin Suraj Pradhan is an independent student researcher meaning he isn't affiliated with any instituition and whose work focuses on pharmacokinetics, drug modeling, and theoretical frameworks in pharmaceutical science. He is the author of the Drug Multiplication Theory (DMI Model), a novel pharmacokinetic approach integrating drug bioavailability, effect strength, and reaction transformation coefficients. His work aims to refine how drug behavior is mathematically understood and applied in clinical pharmacology. Swalin has also published two books of poetry, showcasing his ability to balance rigorous scientific inquiry with emotional and literary depth.
Consulting Pharmacist at Obstet-Rx
I am a third-generation pharmacist with certifications in pharmacogenetics and antepartum doula care, specializing in maternal health and medication safety. After earning my PharmD from Creighton University and a BS in Hospitality from UNLV, I built a career spanning hospital and retail pharmacy, consulting, entrepreneurship, telemedicine, and medical affairs. Currently, I work as a medical science liaison while continuing to consult and practice as a hospital pharmacist. My expertise is grounded in both research and lived experience. After enduring three pregnancies complicated by Hyperemesis Gravidarum (HG), I founded HG Pharmacist® and Obstet-Rx to provide personalized medication guidance, integrate pharmacogenetics into maternal care, and advocate for women worldwide. My research includes genetic predictors of ondansetron effectiveness and recurrence risk for HG, and I have published extensively on maternal health. I also served on the HER Foundation board from 2019 to 2021 and frequently present at professional conferences. As host of the MaternalRx podcast on the Pharmacy Podcast Network, I highlight the pharmacist’s role in maternal outcomes, drawing from my background in specialty diagnostics such as preeclampsia biomarkers, iron deficiency anemia, and oncology supportive therapies. This blend of patient advocacy, clinical expertise, and medical affairs experience positions me as a trusted voice on maternal health, medication management, and the evolving role of pharmacists in healthcare. When I’m not speaking or consulting, I enjoy yoga, ice skating, and time outdoors with my dog. I welcome opportunities to collaborate with media to shed light on maternal health challenges, the importance of personalized medicine, and strategies to improve patient outcomes.
Pharmacist
Pharmacist
Chief Medical Officer at PrivateDoc Limited
Dr. Ruch, as he’s known to the team and patients, is a qualified GP and the Chief Medical Director at PrivateDoc. With over 20 years of clinical experience across both the NHS and private sectors, he brings a wealth of knowledge and a passion for innovation in healthcare. He holds a BSc in Neuroscience and has a special interest in wellness coaching, stress management, and making healthcare more accessible for everyone. At PrivateDoc, Dr. Ruch leads with a clear focus on personalised care and accessibility. He’s a strong believer in taking a holistic view of health - combining physical and mental wellbeing to support long-term results. Whether he’s supporting patients or shaping the future of the service, his calm, compassionate approach is always at the core of what he does.
Featured In:
Toxicologist
I am a reproductive immunotoxicologist by training who works at the intersection of toxicology and epidemiology. My work focuses on how chronic, low-dose environmental chemical exposures influence immune function, reproductive health, and early biological markers of disease. I specialize in interpreting human biomonitoring data and population-based datasets to understand real-world exposure patterns and health risk. My research examines endocrine-disrupting chemicals, pesticides, and other ubiquitous contaminants, with particular attention to vulnerable developmental windows and sex-specific effects. I regularly translate complex toxicological and epidemiologic evidence into clear, actionable insights for nontechnical audiences. This includes communicating uncertainty, biological plausibility, and population relevance without overstating risk. I provide evidence-based commentary on environmental health, reproductive and immune toxicity, and the emerging science of low-dose, chronic chemical exposure as it relates to long-term human health.
Superintendent Pharmacist at Happy Pharmacy
Featured In:
Pharmacist
Head Of Content at PharmacyOnline.co.uk
Featured In:
Chief Medical Officer at Pain Arizona
Featured In:
Medical Reviewer at AddictionResource
CEO of the pharmacy meds at The pharmacy meds
Director, B. Pharm (Hons), MPS CredPharm (MMR & ACOP) at Glen Medicine
Pharma Franchise at DM Pharma Global
Pharmacist and Advanced Clinical Practitioner at Click2Pharmacy
VP of Clinical Strategy & Partnerships at Sevaro Health
Pharmacist & Founder of Pharm Picked at Pharm Picked
Dr. Rob Taylor, Pharm.D., is a licensed pharmacist and founder of Pharm Picked, a wellness brand inspired by his mother’s battle with autoimmune disease. He helps families support immune balance with clean, pharmacist-formulated supplements for kids and adults. Rob combines science-backed care with personal purpose to create trusted solutions for autoimmune and everyday wellness.
Medical Writer at CRO Pharmatrendz Pvt. Ltd.
Fresh, enthusiastic Pharmacy graduate with thorough knowledge in Pharmacology, Pharmaceutics, Medicinal Chemistry. Skilled in Pharmaceutics, Pharmacology, MS Office (Word, Excel, PowerPoint) and Management. Strong operations professional with a Bachelor of Pharmacy focused in Pharmacy from Seemanta Institute of Pharmaceutical Sciences.
Showing 20 of 26 experts
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. It's crucial in healthcare as it ensures the safe use of medications post-market release. Pharmacovigilance experts monitor drug safety, analyze adverse event reports, and recommend actions to minimize risks, ultimately protecting public health and improving patient outcomes.
Being featured in top publications offers numerous benefits for pharmacovigilance experts: 1. Increased professional visibility and recognition in the field 2. Opportunities to share knowledge and influence public understanding of drug safety 3. Potential for new career opportunities or consulting roles 4. Networking with other healthcare professionals and industry leaders 5. Contribution to public health by disseminating accurate information on medication safety This exposure can significantly enhance their professional profile and impact in the pharmacovigilance community.
Pharmacovigilance experts often address a wide range of topics in media interviews, including: 1. Analysis of newly discovered drug side effects 2. The impact of pharmacovigilance on public health policies 3. Emerging technologies in drug safety monitoring 4. Challenges in global adverse event reporting systems 5. Regulatory changes affecting drug safety practices Their insights can provide clarity on complex issues, helping journalists create comprehensive and accurate health-related content.
Publishers can enhance the credibility and depth of their healthcare articles by featuring pharmacovigilance experts. These specialists provide valuable insights on drug safety, regulatory compliance, and emerging trends in medication monitoring. Their expertise can help explain complex topics to readers, such as the impact of new drugs, potential side effects, or the importance of post-marketing surveillance, making the content more authoritative and engaging for healthcare professionals and the general public.